title: The creatine kinase system and cardiomyopathy.
abstract: Changes in the creatine kinase system, cellular energetics, regulation of respiration and alterations in parameters of contractility in experimental animals (myopathic hamsters), and in patients with dilated cardiomyopathy were studied. 31P-NMR methods were used to show that cardiomyopathic hearts are characterized by decreased work index, lower tissue ATP, phosphocreatine, and total creatine contents and diminished creatine kinase activity and energy fluxes. In isolated mitochondria, only the creatine kinase activity was decreased. Both in cardiomyopathic hamsters and human hearts a share of mitochondrial creatine kinase in the total tissue enzyme activity was decreased from 33% to 18% and that of BB elevated from 5% in control to 20%, at an unchanged relative level of MM. In saponins-skinned cardiac fibers on cardiomyocytes creatine (Cr, 25 mM) decreased Km for ADP in regulation of respiration from 133 +/- 20 to 20 +/- 4 microM due to activation of coupled mitochondrial creatine kinase-oxidative phosphorylation reactions in control hamster hearts. In the case of cardiomyopathy it decreased Km for ADP only to 81 +/- 13 microM. In endocardial biopsy samples from the hearts of patients with dilated cardiomyopathy taken during angiography, creatine stimulated respiration was decreased by 36% of control value, which correlated well with increase of end-diastolic pressure and fall in ejection fraction. Thus, changes in mitochondrial creatine kinase expression diminished the efficiency of cellular regulation of respiration in cardiomyopathic hearts that may have functional consequences for hemodynamics or may be adaptive alterations in response to decreased contractility.
authors.affiliation: Laboratory of Bioenergetics, USSR Research Center for Cardiology, Moscow.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Khuchua
authors.forename: E V
authors.initials: EV
authors.lastname: Vasiljeva
authors.forename: J F
authors.initials: JF
authors.lastname: Clark
authors.forename: O V
authors.initials: OV
authors.lastname: Korchazhkina
authors.forename: T
authors.initials: T
authors.lastname: Branishte
authors.forename: V I
authors.initials: VI
authors.lastname: Kapelko
authors.forename: A V
authors.initials: AV
authors.lastname: Kuznetsov
authors.forename: R
authors.initials: R
authors.lastname: Ventura-Clapier
authors.lastname: Steinschneider AYa
authors.forename: V L
authors.initials: VL
authors.lastname: Lakomkin
mesh_terms: D000818:Animals; D009202:Cardiomyopathies / Q000378:metabolism*; D003402:Creatine Kinase / Q000378:metabolism*; D006224:Cricetinae; D004586:Electrophoresis; D004734:Energy Metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D007527:Isoenzymes / Q000378:metabolism; D008297:Male; D008647:Mesocricetus; D008929:Mitochondria, Heart / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010085:Oxidative Phosphorylation
chemical_list: D007527:Isoenzymes; D003402:Creatine Kinase